Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy

10018 Ophthalmology Clinic 0301 basic medicine Inner blood-retina barrier (iBRB) Fundus Oculi Photoperiod 610 610 Medicine & health Mice, Transgenic 2700 General Medicine Diet, High-Fat Capillary Permeability Mice 03 medical and health sciences Vision loss Circadian Clocks Geographic Atrophy Blood-Retinal Barrier Chlorocebus aethiops Animals Humans Claudin-5 Fluorescein Angiography RNA, Small Interfering ARNTL Transcription Factors Magnetic Resonance Imaging Healthy Volunteers Disease Models, Animal Age-related macular degeneration (AMD) Gene Knockdown Techniques
DOI: 10.1172/jci.insight.130273 Publication Date: 2019-08-07T15:00:57Z
ABSTRACT
Age-related macular degeneration (AMD) is the leading cause of central retinal vision loss worldwide, with an estimated 1 in 10 people over the age of 55 showing early signs of the condition. There are currently no forms of therapy available for the end stage of dry AMD, geographic atrophy (GA). Here, we show that the inner blood-retina barrier (iBRB) is highly dynamic and may play a contributory role in GA development. We have discovered that the gene CLDN5, which encodes claudin-5, a tight junction protein abundantly expressed at the iBRB, is regulated by BMAL1 and the circadian clock. Persistent suppression of claudin-5 expression in mice exposed to a cholesterol-enriched diet induced striking retinal pigment epithelium (RPE) cell atrophy, and persistent targeted suppression of claudin-5 in the macular region of nonhuman primates induced RPE cell atrophy. Moreover, fundus fluorescein angiography in human and nonhuman primate subjects showed increased retinal vascular permeability in the evening compared with the morning. These findings implicate an inner retina-derived component in the early pathophysiological changes observed in AMD, and we suggest that restoring the integrity of the iBRB may represent a novel therapeutic target for the prevention and treatment of GA secondary to dry AMD.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (48)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....